TGFBR2 and atherosclerosis: Accordingly, endothelial deletion of ALK5 or TGFBR2 in the ApoE−/− atherosclerosis mouse model reduces atherosclerosis plaque burden, plaque collagen content, fibronectin deposition and VCAM-1 expression [62].